Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19

Gregorio Benitez,Fadi Shehadeh,Evangelia K. Mylona,Quynh-Lam Tran,Maria Tsikala-Vafea,Eleftheria Atalla,Matthew Kaczynski,Eleftherios Mylonakis

International Immunopharmacology（2023）

引用 0|浏览2

暂无评分

摘要

•Lymphocytopenia is common in patients with COVID-19 and is linked with poor outcomes.•Tα1 may reverse lymphocytopenia and severe lymphocytopenia within 3 days.•Effect on restoring lymphocyte count may be irrespective of baseline oxygen support.

查看译文

关键词

Thymalfasin,Thymosin-alpha-1,COVID-19,Lymphocytopenia,Lymphopenia,Severe COVID-19

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要